Sept. 27, 2010: Genzyme's woes

GREATER BOSTON Greater Boston

A production of  

 

Recent Episodes

Supported by:

Jan. 30, 2013: Interim Senator Mo Cowan

Jan. 30, 2013: Interim Senator Mo Cowan

Greater Boston

Jan. 30, 2013: Medical Homes

Jan. 30, 2013: Medical Homes

Greater Boston

Jan. 30, 2013: Stephen Davis

Jan. 30, 2013: Stephen Davis

Greater Boston

Jan. 31, 2013: Caught In The Act

Jan. 31, 2013: Caught In The Act

Greater Boston

Jan. 31, 2013: From The Archives

Jan. 31, 2013: From The Archives

Greater Boston

Jan. 31, 2013: Lawrence Wright

Jan. 31, 2013: Lawrence Wright

Greater Boston

Schedule

Sunday
2/3/13 9:30 AM
WGBH 44
Monday
2/4/13 6:00 AM
WGBH World
Monday
2/4/13 12:00 PM
WGBH World
Monday
2/4/13 7:00 PM
WGBH 2
TBA TBA TBA TBA

Latest Comments


Related Content

Genzyme, the largest biotech company in the Boston-area, has been hit by hard times recently. A virus contaminated the biotech giant's Allston plant and resulted in a $175 million fine from the FDA. Now, a French drug company is interested in purchasing Genzyme. Business contributor Kris Frieswick joins Emily to gauge the impact this is having on Genzyme and biotech in Boston.

Greater Boston updates from WGBH

See a sample »

   

Masterpiece Sweepstakes 2013